| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.025 | 23.859 | 20.690 | 19.999 | 20.042 | 26.305 | 30.777 | 4.515 | 13.414 | 12.359 |
| Total Income - EUR | 11.864 | 24.679 | 20.600 | 22.105 | 19.281 | 24.774 | 31.033 | 25.915 | 29.033 | 27.095 |
| Total Expenses - EUR | 27.894 | 17.003 | 16.819 | 13.547 | 13.834 | 16.694 | 21.819 | 35.188 | 40.924 | 30.901 |
| Gross Profit/Loss - EUR | -16.031 | 7.676 | 3.781 | 8.557 | 5.447 | 8.080 | 9.214 | -9.273 | -11.890 | -3.806 |
| Net Profit/Loss - EUR | -16.129 | 7.084 | 3.593 | 8.219 | 5.266 | 7.594 | 8.590 | -9.319 | -12.036 | -3.934 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Biobrotland Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.978 | 11.658 | 6.407 | 2.694 | 2.005 | 9.938 | 8.045 | 7.123 | 5.670 | 4.327 |
| Current Assets | 5.990 | 7.320 | 7.680 | 7.911 | 7.190 | 8.486 | 10.763 | 9.430 | 12.951 | 10.991 |
| Inventories | 1.309 | 2.115 | 1.988 | 4.057 | 3.218 | 1.626 | 1.846 | 5.024 | 5.562 | 3.095 |
| Receivables | 338 | 11 | 882 | 118 | 1.111 | 3.024 | 657 | 1.198 | 714 | 618 |
| Cash | 4.343 | 5.193 | 4.810 | 3.735 | 2.861 | 3.836 | 8.259 | 3.207 | 6.675 | 7.278 |
| Shareholders Funds | -17.602 | -10.339 | -6.571 | 1.769 | 7.001 | 9.810 | 18.183 | 8.920 | -3.143 | -7.059 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 40.571 | 29.317 | 20.657 | 8.837 | 2.195 | 8.614 | 624 | 7.632 | 21.764 | 22.378 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Biobrotland Srl